.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Mallinckrodt
Covington
Baxter
Boehringer Ingelheim
Cantor Fitzgerald
Chubb
Cerilliant
AstraZeneca

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
Abstract: A synthesis approach providing an early ring attachment via a bromination to compound I-I yielding compound II-II: ##STR00001## whereby a final product such as AA: ##STR00002## can be synthesized. In particular, the 2,4-difluorophenyl-containing sidechain is attached before creation of the additional ring Q.
Inventor(s): Yoshida; Hiroshi (Osaka, JP), Taoda; Yoshiyuki (Osaka, JP), Johns; Brian (Research Triangle Park, NC), Kawasuji; Takashi (Osaka, JP), Nagamatsu; Daiki (Osaka, JP)
Assignee: Shionogi & Co., Ltd. (Osaka, JP) ViiV Healthcare Company (Research Triangle Park, NC)
Filing Date:Dec 08, 2009
Application Number:13/128,992
Claims:1. A process of for the preparation of a pyridone compound of formula (AA), (BB) or (CC): ##STR00039## comprising the steps of: P-1) brominating a compound of the following formula (I-I) to produe a bromine compound of the following formula (II-II): ##STR00040## wherein R is --CHO, --CH(OH).sub.2, --CH(OH)(OR.sup.4), --CH(OH)--CH.sub.2OH or --CH(OR.sup.5)(OR.sup.6); P.sup.1 is H or a hydroxyl protecting group; P.sup.3 is H or a carboxy protecting group; R.sup.4 is lower alkyl; R.sup.5 and R.sup.6 are independently lower alkyl or R.sup.5 and R.sup.6 can be alkyl and joined to form a 5-, 6-, or 7-membered ring, and P-2) creating the 2,4-di-fluorophenyl-CH.sub.2--NH--C(O)-- sidechain with the reactants 2,4-di-fluorophenyl-CH.sub.2--NH.sub.2 and carbon monoxide.

2. A process is provided for the preparation of a pyridone compound of the following formula (AA), (BB) or (CC): ##STR00041## comprising the steps of: P-1) brominating a compound of the following formula (I-I) to produce a bromine compound of the following formula (II-II): ##STR00042## wherein R is --CHO, --CH(OH).sub.2, --CH(OH)(OR.sup.4), --CH(OH)--CH.sub.2OH or --CH(OR.sup.5)(OR.sup.6); P.sup.1 is H or a hydroxyl protecting group; P.sup.3 is H or a carboxy protecting group; R.sup.4 is lower alkyl; R.sup.5 and R.sup.6 are independently lower alkyl or R.sup.5 and R.sup.6 can be lower alkyl and joined to form a 5-, 6-, or 7-membered ring, P-2) creating the 2,4-di-fluorophenyl-CH.sub.2--NH--C(O)-- sidechain with the reactants 2,4-di-fluorophenyl-CH.sub.2--NH.sub.2 and carbon monoxide to form a compound of formula III-III: ##STR00043## P-3) condensing and debenzylating a compound of formula III-III to form a compound of formula AA, BB, or CC.

3. The process according to claim 1, wherein said step P-2) is carried out before creation of the Q ring.

4. The process according to claim 1, wherein said pyridone compound is of the formula AA.

5. The process according to claim 1, wherein said pyridone compound is of the formula BB.

6. The process according to claim 1, wherein said pyridone compound is of the formula CC.

7. The process according to claim 1, wherein said step P-2) is carried out after creation of the Q ring.

8. The process according to claim 7, wherein said pyridone compound is of the formula AA.

9. The process of claim 7, wherein said pyridone compound is of the formula BB.

10. The process of claim 7, wherein said pyridone compound is of the formula CC.

11. A process according to claim 1 wherein P.sup.1 is benzyl; P.sup.3 is methyl; and R is --CHO, --CH(OH)(OR.sup.4), --CH(OR.sup.5)(OR.sup.5) wherein R.sup.4 and R.sup.5 are lower alkyl.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
Baxter
Deloitte
Julphar
Harvard Business School
UBS
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot